프리마켓
로그인 회원가입
RDGT
RDGT
Ridgetech Inc
7월 27일 4:00 PM ET (한국 7/28 05:00)
$1.23
-0.02 ▼ -1.60%
🌙 7월 28일 8:52 AM ET (한국 7/28 21:52)
$1.28
+0.05 ▲ +4.20%

리지텍(RDGT) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$1M
스몰캡
P/E
-
배당수익률
없음
52주 위치
0%
저점 +4% · 고점 -100%
애널리스트
-
C+
Fundamental health
vs. Healthcare 초소형주
수익성
Top 19%
성장
Top 27%
밸류에이션
Top 96%
재무 안정
Top 48%
Index -P/E -EPS (ttm) -85.73Insider Own -Shs Outstand 0.9MPerf Week -22.15%
Market Cap 0.00BForward P/E -EPS next Y -Insider Trans -Shs Float -Perf Month -18%
Enterprise Value -0.01BPEG -EPS next Q -Inst Own 11.39%Short Float -Perf Quarter -33.15%
Income -0.00BP/S 0.01EPS this Y -Inst Trans 3.34%Short Ratio 0.02Perf Half Y -99.68%
Sales 0.11BP/B 0EPS next 5Y -ROA 0.97%Short Interest 0.05MPerf YTD -99.71%
Book/sh 762.93P/C 0.06EPS past 3/5Y 83.42% 52.73%ROE 2.96%52W High -99.84% ($760.50)Perf Year -99.37%
Cash/sh 20.15P/FCF 0.07Sales past 3/5Y -9.97% 0.45%ROIC -11.24%52W Low 4.35% ($1.18)Perf 3Y -99.89%
Dividend Est. -EV/EBITDA -5.16EPS Y/Y TTM 75.39%Gross Margin 3.27%Volatility(W/M) 16.58% 16.88%Perf 5Y -100%
Dividend TTM -EV/Sales -0.11Sales Y/Y TTM -24.14%Oper. Margin 1%ATR (14) 0.45Perf 10Y -100%
Dividend Ex-Date -Quick Ratio 1.49EPS Q/Q 96.35%Profit Margin -3%RSI (14) 36.55Recom -
Dividend Gr. 3/5Y -Current Ratio 1.82Sales Q/Q 17.7%SMA20 -15.55% ($1.46)Beta -0.16Target Price -
Payout -Debt/Eq 0.16Earnings -SMA50 -18.36% ($1.51)Rel Volume 0.08Prev Close $1.25
Employees -LT Debt/Eq 0EPS/Sales Surpr. -SMA200 -99.43% ($215.79)Avg Volume(3M) 2.97MPrice $1.23
IPO 2008/5/16Option/Short No/YesTrades 807Volume 248,598Change -1.6%
Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.

📊 Ridgetech Inc (RDGT) Investment Analysis

What kind of company is Ridgetech Inc?

리지텍(RDGT) 방어주
Healthcare · Pharmaceutical Retailers
Small-Cap — Low Volume, High Volatility

💊 A pharmaceutical retail and distribution company headquartered in Hangzhou, China. It sells prescription drugs, over-the-counter (OTC) medicines, traditional Chinese medicine (TCM), health supplements, and medical devices through three channels: offline pharmacies, online pharmacies, and pharmaceutical wholesale. The company is listed on Nasdaq and changed its name from the former China Jo-Jo Drugstores to Ridgetech in 2024.

Learn more about Ridgetech Inc →
Market Cap
$0.0B
Approx. KRW 0.0 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank5868
IPO2008/05/16
Current Price$1.23 ≈ 1,685원
NASD · China

Key Events

예정된 이벤트가 없습니다

RDGT의 다음 실적 발표일이나 배당 일정이 아직 수집되지 않았습니다.

  • 실적 발표는 보통 분기마다 있습니다
  • 배당주는 연 1~4회 배당락일이 있습니다
전체 경제/실적 캘린더 보기 →

Is it profitable?

Financially sound but profitability is low
Losses or thin margins — early-stage growth or weakening competitiveness
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
1.0%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 초소형주 Median -226.6% · Top tier
💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수
Net Margin
Share of revenue left after taxes and interest are paid
-3.0%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
3.3%
✓ 부진
My positionBottom 25%
Low range Average High range
Healthcare 초소형주 Median 42.6% · Bottom 25%
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROE
Annual return earned on shareholders' equity (15%+ is strong)
3.0%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 초소형주 Median -98.0% · Top tier
💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)
ROA
Annual earnings relative to total company assets
1.0%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 초소형주 Median -59.3% · Top tier
💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수
ROIC
Return generated per dollar invested in the business
-11.2%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
0.16
✓ Healthy debt
My positionMid-range
Low range Average High range
Healthcare 초소형주 Median 0.09
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
1.82
✓ 양호
My positionMid-range
Low range Average High range
Healthcare 초소형주 Median 2.76
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
1.49
✓ 양호
My positionMid-range
Low range Average High range
Healthcare 초소형주 Median 2.54
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Outlook data is insufficient

Analyst estimates and price targets have not been collected.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Average Growth
Mid-range within the industry
Margin-Driven Growth EPS is growing while revenue is flat — gains may come from cost cuts, so watch sustainability
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
+83.4%
우수
My positionTop 25%
Low range Average High range
방어주 초소형주 Median 30.0% · Top 11%
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
+52.7%
우수
My positionTop 25%
Low range Average High range
방어주 초소형주 Median 16.4% · Top 19%
Past 5-Year Revenue
How much revenue grew over the past 5 years
+0.5%
평균
My positionMid-range
Low range Average High range
방어주 초소형주 Median 2.1% · Bottom 47%
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
+17.7%
양호
My positionMid-range
Low range Average High range
방어주 초소형주 Median -4.5% · Top 27%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

Has the stock risen over the long term?

Long-term weakness — -168%p below the market
RDGT -100.0% · S&P 500 +68.3%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-168.3%p
Significantly behind the market
vs Health Care (XLV)
-124.5%p
Significantly behind the sector average
1-year basis
vs S&P 500
-115.4%p
Significantly behind the market
vs Health Care (XLV)
-119.1%p
Significantly behind the sector average
Current position within 52-week range
Low (-4.3%p) High (-99.8%p)
Current price is 4.3% above the 52-week low and 99.8% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-99.4%
Annualized volatility
852.1%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔵
Current diagnosis · 2026-07-27
Oversold zone — rebound potential

Current price $1.23 fell below the lower band ($1.24). Selling pressure excessive; worth watching for a short-term bounce. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡
Current diagnosis · 2026-07-27
Neutral zone — weak trend

MACD -0.484 · Signal -0.661 · Hist 0.177. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴
Current diagnosis · 2026-07-27
Bearish zone

RSI 36.3 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 8.1.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

In line with the industry average
Cheap on Vs. Sales, Pricey on Vs. Assets, In line with peers on Vs. Cash Flow
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
🏢 Vs. Assets Pricey
🧾 Vs. Sales Cheap
💧 Vs. Cash Flow Mid-range
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
0.00x
✓ Very pricey
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
0.01x
✓ Very cheap
My positionTop 5%
Low range Average High range
Healthcare 초소형주 median 3.22x · Top 1% — relatively cheap within the industry
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
💧 Vs. Cash Flow
EV/EBITDA Enterprise Value Multiple
Total enterprise value ÷ operating cash earnings — a benchmark for M&A
-5.16x
✓ Very pricey
💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)
💧 Vs. Cash Flow
P/FCF Price-to-Free-Cash-Flow Ratio
Price vs. actual cash generation — lower means more efficient
0.07x
✓ Very cheap
My positionTop 5%
Low range Average High range
Healthcare 초소형주 median 14.15x · Top 1% — relatively cheap within the industry
💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: 전체 시장

Who owns it?

Ownership flow is positive
Institutional net buying +3.3% · Short interest up +3.7pp over last 82d
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
-
No trading data for Insiders
🏦 Institutions (funds & investors)
+3.3%
Institutions net buying
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 11.4%
Retail-led
Healthcare 초소형주 Median 14.2%
🧑‍💼 Insiders 0.0%
Low, common among large-caps
Healthcare 초소형주 Median 16.1%
👤 Retail investors (estimated) 88.6%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
-
Past 82 days 📈 +3.7%p increase
Short interest days to cover
0.0 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 0.9M주
Float (tradable shares) -
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 82 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
RDGT RDGT This Stock
$1.1M- 0.0 2.96% - -1.6%
LLY
$1.13T43.1 36.2 107.64% 0.58% +0.1%
JNJ
$640.9B30.8 7.5 25.74% 2.02% +1.0%
ABBV
$453.9B126.7 - 15221.82% 2.67% -0.9%
UNH
$379.3B26.9 3.9 12.49% 2.16% -0.7%
MRK
$323.0B36.8 7.0 18.97% 2.5% -0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

FAQ

What kind of company is 리지텍(RDGT)?

리지텍(RDGT) belongs to the Healthcare sector and operates in the Pharmaceutical Retailers industry.

What is the market cap of RDGT?

The market cap of RDGT is approximately $1M, ranking 5,868 within its sector.

What is the 52-week high and low for RDGT?

RDGT has recorded a 52-week high of $760.50 and a low of $1.18.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.